DDrare
Disease
Drug
Target Gene/Pathway
お問合せ先
EN
Nilotinib (Tasigna)
( DrugBank:
Nilotinib
/ KEGG DRUG:
Nilotinib
)
1 disease
告示番号
疾患名
(ページ内リンク)
臨床試験数
51
全身性強皮症
1
51. 全身性強皮症
臨床試験数
:
525
/
薬物数
:
565
- (
DrugBank
:
148
) /
標的遺伝子数
:
114
-
標的パスウェイ数
:
217
10
50
100
ALL
trials per page:
Showing 1 to 1 of 1 trials
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT01166139
(
ClinicalTrials.gov
)
July 2010
20100700
1/7/2010
20100701
Nilotinib
in the Treatment of Systemic Sclerosis
Phase IIA Study of the Safety and Tolerability of the Use of
Nilotinib
in the Treatment of Systemic Sclerosis
Phase IIA Study of the Safety and Tolerability of the Use of
Nilotinib
in the Treatment of Systemic S ...
Systemic Sclerosis
Drug:
Nilotinib
(Tasigna)
Hospital for Special Surgery, New York
Rudolph Rupert Scleroderma Program;Novartis Pharmaceuticals
Completed
18 Years
N/A
All
10
Phase 2
United States